SCHEMBL7777358

SCHEMBL7777358

Cc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)n[nH]c2C(=O)Nc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.48
CA1 P00915 5/20 0.48
CA2 P00918 5/20 0.48
CA4 P22748 2/20 0.48
CA7 P43166 2/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
POLB P06746 4/20 0.48
MAPT P10636 3/20 0.48
PSMD14 O00487 2/20 0.48
CACNA1B Q00975 2/20 0.48
APBA1 Q02410 2/20 0.48
RECQL P46063 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
SAE1 Q9UBE0 1/20 0.48
UBA2 Q9UBT2 1/20 0.48
PTPN7 P35236 1/20 0.47
CA12 O43570 3/20 0.46
CA9 Q16790 3/20 0.46
CDK2 P24941 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7772984 0.90 CNR1 (0.46) PTGS2MEN1KMT2ACNR1LMNA
SCHEMBL7779394 0.89 CA1 (0.54) PTGS2CA1CA2CA4CA7
SCHEMBL7780065 0.84 CA9 (0.46) PTGS2CA1CA2CA4CA7
SCHEMBL8166781 0.83 CA12 (0.54) CA1CA2CA7PTPN7CA12
SCHEMBL7780566 0.82 CA9 (0.51) PTGS2CA1CA2CA4CA7
SCHEMBL7779971 0.81 CNR1 (0.46) PTGS2CA1CA2CA4CA7
SCHEMBL7777646 0.81 CA1 (0.53) PTGS2CA1CA2CA4CA7
SCHEMBL7773173 0.76 PTGS2 (0.52) PTGS2CA1CA2CA4CA7
SCHEMBL7777827 0.74 PTGS2 (0.51) PTGS2CA1CA2CA7MEN1
SCHEMBL8179843 0.73 CA1 (0.55) PTGS2CA1CA2CA4CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed